切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2018, Vol. 07 ›› Issue (02) : 141 -144. doi: 10.3877/cma.j.issn.2095-3224.2018.02.008

所属专题: 文献

论著

长期甲氨蝶呤治疗硫唑嘌呤干预无效型溃疡性结肠炎的临床研究
栾兴龙1,(), 苏峰1, 程元星1   
  1. 1. 274300 山东,济宁医学院附属湖西医院消化内科
  • 收稿日期:2017-07-17 出版日期:2018-04-25
  • 通信作者: 栾兴龙

Clinical study of long-term methotrexate in the treatment of ulcerative colitis with azathioprine ineffective intervention

Xinglong Luan1,(), Feng Su1, Yuanxing Cheng1   

  1. 1. Department of Gastroenterology, The Hu Xi Hospital Affilliated Ji Ning Medical College, Shandong, Shan Xian 274300, China
  • Received:2017-07-17 Published:2018-04-25
  • Corresponding author: Xinglong Luan
  • About author:
    Corresponding author: Luan Xinglong, Email:
引用本文:

栾兴龙, 苏峰, 程元星. 长期甲氨蝶呤治疗硫唑嘌呤干预无效型溃疡性结肠炎的临床研究[J]. 中华结直肠疾病电子杂志, 2018, 07(02): 141-144.

Xinglong Luan, Feng Su, Yuanxing Cheng. Clinical study of long-term methotrexate in the treatment of ulcerative colitis with azathioprine ineffective intervention[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2018, 07(02): 141-144.

目的

研究长期甲氨蝶呤(MTX)治疗硫唑嘌呤(AZA)干预无效型溃疡性结肠炎(UC)的疗效。

方法

选取济宁医学院92例AZA干预无效型UC患者为研究对象,按随机数表法分为对照组和观察组,每组各46例,观察组予以MTX肌肉注射治疗,持续治疗1年,对照组予以MTX肌肉注射治疗,持续治疗半年,后改安慰剂继续治疗半年。比较两组临床疗效差异,分析两组血红蛋白(HB)、白蛋白(ALB)、血沉(ESR)、C-反应蛋白(CRP)、血小板(PLT)水平,同时了解两组不良反应发生率。

结果

两组治疗半年后临床疗效差异无显著统计学意义(χ2=0.045;P>0.05)。观察组治疗1年总有效率高于观察组治疗半年(χ2=11.683,P<0.05),也高于对照组治疗1年(χ2=17.692,P<0.05)。观察组HB、ALB指标在治疗前(t=4.181,4.599)、治疗半年(t=7.950,9.756)、治疗1年后(t=3.635,5.180),均成升高趋势(均P<0.05),ESR、CRP、PLT在治疗前(t=10.789,16.959,62.326)、治疗半年(t=22.270,23.002,75.209)、治疗1年后(t=16.339,9.553,11.515)均呈降低趋势(均P<0.05)。对照组治疗半年(t=4.465,4.405)及治疗1年(t=3.942,3.321)HB、ALB均明显高于治疗前,ESR、CRP、PLT治疗半年(t=10.743,17.248,61.852)及治疗1年(t=9.670,15.893,60.567)均明显低于治疗前(均P<0.05),而治疗半年与治疗1年各指标比较差异无显著统计学意义(t=0.496,1.150,1.200,0.233,0.312;均P>0.05)。治疗1年后,观察组HB、ALB均明显高于对照组(t=3.893,6.240;均P<0.05),ESR、CRP、PLT均明显低于对照组(t=17.009,9.971,11.662;均P<0.05)。两组不良反应发生率差异无统计学意义(χ2=1.848,P>0.05)。

结论

长期MTX用于AZA干预无效UC临床疗效佳,并可改善体内营养状况及凝血功能,同时能降低体内炎症反应,缓解病情,安全性高,具有较好的临床应用价值。

Objective

To study the efficacy of long-term methotrexate (MTX) in the treatment of ulcerative colitis (UC) with azathioprine (AZA) ineffective intervention.

Methods

Ninety-two patients with UC ineffective in the treatment of AZA, were randomly divided into two groups, forty-six cases in each group. The control group was given intramuscular injection of MTX for one year. The control group was treated with placebo for half a year after having finished intramuscular injection of MTX for six months. We Compare the differences of clinical efficacy in two groups, and analyze the level of hemoglobin (HB), albumin (ALB), blood sink (ESR), C-reactive protein (CRP), platelet (PLT) in two groups, and learn the incidence of adverse reactions in the two groups.

Results

There was no significant difference in clinical curative effect between the two groups after six months (χ2=0.045; P>0.05).The total effective rate in the observation group after one year was higher than that for six months and that in control group (χ2 = 11.683 and 17.692 respectively; P<0.05). The levels of HB and ALB were increased, and CRP, ESR and PLT were decreased during the treatment (t=4.181, 4.599, 10.789, 16.959, 62.326, 7.950, 9.756, 22.270, 23.002, 75.209, 3.637, 5.180, 16.339, 9.553, 11.515 respectively; P<0.05).The levels of HBsAg and ALT were significantly higher in the control group than those before treatment, and the levels of CRP, ESR and PLT were significantly lower than those before treatment (t=4.465, 4.405, 10.743, 17.248, 61.852, 3.942, 3.321, 9.670, 15.893, 60.567 respectively, P<0.05).There was no significant difference between the six months of treatment and the treatment for 1 year (t=0.496, 1.150, 1.200, 0.233, 0.312 respectively, P>0.05). After 1 year of treatment, HB and ALB in the observation group were significantly higher than those in the control group, CRP, ESR and PLT were significantly lower than those in the control group (t=3.893, 6.240, 17.009, 9.971, 11.662 respectively, P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (χ2=1.848, P>0.05).

Conclusion

MTX treatment of UC, which is ineffective in the treatment of azathioprine (AZA), can improve the nutritional status of the body, coagulation function, and reduce the body′s inflammatory response. It can control the disease and has high safety with a good clinical value.

表1 两组临床疗效的比较(例,%)
表2 两组HB、ALB、ESR、CRP、PLT水平比较(±s
表3 两组不良反应的比较(例,%)
[1]
赵曼,高峰.溃疡性结肠炎发病机制研究进展[J].现代生物医学进展, 2010, 10(16):1501-1502.
[2]
杨泽云.溃疡性结肠炎的发病机制与治疗进展[J].临床合理用药杂志, 2015, 8(30):180-181.
[3]
安子元.溃疡性结肠炎新的诊断标准[J].新消化病学杂志, 1994, 2(1):57-57.
[4]
中华医学会消化病学分会炎症性肠病协作组.对我国炎症性肠病诊断治疗规范的共识意见[J].中华消化杂志, 2007, 27(8):545-550.
[5]
雷晓燕,崔梅花.溃疡性结肠炎的治疗进展[J].山东医药, 2014, 54(6):99-102.
[6]
李晓敏.溃疡性结肠炎的临床治疗[J].中国卫生标准管理, 2015, 6(7):42-43.
[7]
李玥,钱家鸣.免疫抑制剂在炎症性肠病治疗中的应用进展[J].临床荟萃, 2016, 31(8):824-827.
[8]
李宝全,安翠平,赵小洁,等.溃疡性结肠炎患者血清NGAL检测及意义[J].标记免疫分析与临床, 2015, 22(2):113-115.
[9]
王玉霞.低分子肝素联合甲氨喋呤治疗难治性溃疡性结肠炎的临床研究[J].结直肠肛门外科, 2017, 23(1):78-82.
[10]
李明明,王启之.溃疡性结肠炎药物治疗的研究进展[J].胃肠病学和肝病学杂志, 2017, 26(4):458-461.
[1] 张曼, 李明庆, 李军苗. 当归四逆汤联合甲氨蝶呤治疗类风湿关节炎的疗效[J]. 中华关节外科杂志(电子版), 2023, 17(05): 648-652.
[2] 邓瑶, 喻韬, 陈小璐, 罗蓉. 热性感染相关性癫痫综合征患儿的临床及随访分析[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(06): 645-651.
[3] 孔欣, 宋宝全, 刘吟, 张剑, 仇惠英, 吴德沛. 异基因造血干细胞移植并发难治性呃逆一例[J]. 中华移植杂志(电子版), 2023, 17(04): 253-255.
[4] 徐海, 伊尔范江·亚力坤, 加素尔·巴吐尔, 吴海岐, 谭震宇, 艾尔肯·吐尔逊, 陆立. 膀胱全切及双"拖入式"改良Bricker术治疗结核性膀胱挛缩和炎性尿道狭窄[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(04): 302-305.
[5] 张剑明, 叶文慧, 牟廷裕, 蓝孝亮, 邓海军. 腹腔镜全结直肠切除、回肠J型储袋-肛管吻合术近期并发症及防治策略[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 388-395.
[6] 杨文蔚, 牛雅茹, 孙永琨. 转移性结直肠癌三线治疗的研究现状及进展[J]. 中华结直肠疾病电子杂志, 2022, 11(05): 415-419.
[7] 唐悆, 邓宏伟, 陶政旸, 吕宗岳. 基于Gabor视标的视知觉学习治疗难治性弱视的临床疗效观察[J]. 中华眼科医学杂志(电子版), 2023, 13(03): 134-139.
[8] 唐先勇, 许骏, 黎开谷, 于炎冰. 颈动脉外膜交感神经切除术治疗难治性抽动障碍的疗效分析[J]. 中华脑科疾病与康复杂志(电子版), 2022, 12(04): 241-244.
[9] 屈霄, 王靓, 陆萍, 何斌, 孙敏. 外周血炎症因子及肠道菌群特征与活动性溃疡性结肠炎患者病情的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 466-470.
[10] 朱风尚, 舍玲, 丁永年, 杨长青. 警惕炎症性肠病与少见肠道疾病的鉴别诊断[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 273-276.
[11] 陈婷婷, 江学良, 余佳丽, 柯剑林. 干细胞治疗炎症性肠病的安全性[J]. 中华消化病与影像杂志(电子版), 2023, 13(04): 193-198.
[12] 余佳丽, 江学良. 从炎症性肠病治疗策略转变看生物制剂应用进展[J]. 中华消化病与影像杂志(电子版), 2023, 13(03): 129-134.
[13] 江学良, 柯剑林, 陈婷婷, 余佳丽. 不同剂量双歧杆菌四联活菌片对轻、中度活动期溃疡性结肠炎患者肠道菌群失调的影响[J]. 中华消化病与影像杂志(电子版), 2022, 12(05): 260-264.
[14] 王梦, 徐东燕, 张晓雨, 赵海剑. 伴有肛周疾病的炎症性肠病患者肛门功能及生活质量分析[J]. 中华消化病与影像杂志(电子版), 2022, 12(04): 224-227.
[15] 徐玲玲, 田汉, 闻萍, 何伟春. 利妥昔单抗治疗难治性微小病变性肾病一例并文献复习[J]. 中华临床医师杂志(电子版), 2023, 17(05): 617-621.
阅读次数
全文


摘要